US Stock MarketDetailed Quotes

CRSP CRISPR Therapeutics

Watchlist
  • 47.010
  • -0.850-1.78%
Close Aug 9 16:00 ET
  • 47.200
  • +0.190+0.40%
Post 20:02 ET
4.00BMarket Cap-14690P/E (TTM)

CRISPR Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

CRISPR Therapeutics Earnings Date

Currency: USD

Period

Q2 FY2024 Earnings

--

Revenue(YoY)

517.00K

-99.26%
EPS(YoY)

-1.49

-52.04%
Analyst Rating

Buy

Aug 9, 2024

CRISPR Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 21 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 34.109M--
--2024/Q3-- / 8.477M--
--2024/Q2517.000K / 13.613M--
--2024/Q1504.000K / 26.494M--
--2023/Q4201.206M / 123.085M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 34.109M--
--2024/Q3-- / 8.477M--
--2024/Q2517.000K / 13.613M--
--2024/Q1504.000K / 26.494M--
--2023/Q4201.206M / 123.085M--

Unlock Free Earnings Estimates

CRISPR Therapeutics Earnings Reports

  • CRISPR Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 5 16:13 ET

  • CRISPR Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 8 16:29 ET

  • CRISPR Therapeutics | 10-K: FY2023 Annual Report

    Feb 21 07:55 ET

  • CRISPR Therapeutics: Q3 2023 Earnings Report

    Nov 6, 2023 16:42 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Aug 9, 2024

    Buy

    • Buy

      55.56%

    • Hold

      33.33%

    • Sell

      11.11%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg
    Concept ARK Portfolio
    ARK Portfolio
    Intraday+0.84%
    Gene Editing
    Gene Editing
    Intraday+0.23%